{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:31:18Z","timestamp":1788813078361,"version":"build-2803163510"},"reference-count":44,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"unspecified","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the Key Research and Development Project of Chengdu City","award":["2024-YF05-00546-SN"],"award-info":[{"award-number":["2024-YF05-00546-SN"]}]},{"name":"the Key Research and Development Project of Sichuan Province","award":["2023YFS0171"],"award-info":[{"award-number":["2023YFS0171"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2025,12,5]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immunotherapy is considered a promising treatment approach for advanced biliary tract cancers (BTCs), but only a small number of patients can respond to immunotherapy. This study aimed to develop and validate a clinical-radiomics nomogram integrating radiomic features from lymph nodes (LNs) for predicting immunotherapy efficacy in advanced BTCs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 258 patients with advanced BTCs were enrolled, comprising 206 patients in the retrospective cohort and 52 patients in the prospective cohort. Radiomic features were extracted from the LNs. The maximum relevance and minimum redundancy and least absolute shrinkage and selection operator were used to develop the radiomics signature (Rad-score). Univariate analysis and multivariate logistic regression (LR) were used to construct the clinical model. A clinical-radiomics nomogram was constructed using LR. The performance of all the models was analyzed using receiver operating characteristic curves.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nine radiomic features were combined to construct the Rad-score. The nomogram incorporated the six clinical parameters and the Rad-score, and achieved the best discriminative ability with the areas under the curve (AUCs) of 0.899, 0.843 and 0.874 in the training, validation and testing cohorts. The clinical model showed better predictive performance than the Rad-score with the AUCs of 0.834, 0.878 and 0.740 in the training, validation and testing cohorts. The calibration curve and Brier score indicated the goodness-of-fit of the nomogram. Patients with higher nomogram scores had better overall survival (OS) and progression-free survival (PFS) in comparison to those with low scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The clinical-radiomics nomogram showed promising performance for predicting the response to immunotherapy in patients with advanced BTCs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2025-012416","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T19:00:19Z","timestamp":1767121219000},"page":"e012416","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical-radiomics nomogram integrating lymph node radiomic features to predict immunotherapy response in advanced biliary tract cancers"],"prefix":"10.1136","volume":"13","author":[{"given":"Qian","family":"Li","sequence":"first","affiliation":[{"name":"Department of Radiology, West China Hospital of Medicine, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, West China Hospital of Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Shanghai United Imaging Intelligence, Shanghai, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haopeng","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Radiology, West China Hospital of Medicine, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Radiology, West China Hospital of Medicine, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, West China Hospital of Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixing","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Radiology, West China Hospital of Medicine, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4486-2641","authenticated-orcid":false,"given":"Ji","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, West China Hospital of Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"2025123022310402000_13.12.e012416.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0310-z"},{"key":"2025123022310402000_13.12.e012416.2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21708"},{"key":"2025123022310402000_13.12.e012416.3","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14089"},{"key":"2025123022310402000_13.12.e012416.4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11523-023-01024-x","article-title":"Pemigatinib: A Review in Advanced Cholangiocarcinoma","volume":"19","author":"Frampton","year":"2024","journal-title":"Target Oncol"},{"key":"2025123022310402000_13.12.e012416.5","unstructured":"American Cancer Society Medical and Editorial Content Team . Survival rates for bile duct cancer. n.d. Available: https:\/\/www.cancer.org\/cancer\/types\/bile-duct-cancer\/detection-diagnosis-staging\/survival-by-stage.html"},{"key":"2025123022310402000_13.12.e012416.6","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1200\/JCO.2022.40.4_suppl.378","article-title":"A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1","volume":"40","author":"Oh","year":"2022","journal-title":"JCO"},{"key":"2025123022310402000_13.12.e012416.7","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","article-title":"Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Kelley","year":"2023","journal-title":"The Lancet"},{"key":"2025123022310402000_13.12.e012416.8","doi-asserted-by":"crossref","first-page":"1493234","DOI":"10.3389\/fimmu.2025.1493234","article-title":"Efficacy and safety of immune checkpoint inhibitors in advanced biliary tract cancer: a real-world study","volume":"16","author":"Zheng","year":"2025","journal-title":"Front Immunol"},{"key":"2025123022310402000_13.12.e012416.9","doi-asserted-by":"crossref","first-page":"1512972","DOI":"10.3389\/fimmu.2024.1512972","article-title":"Effect of immune checkpoint inhibitor time-of-day infusion on survival in advanced biliary tract cancer: a propensity score-matched analysis","volume":"15","author":"Zheng","year":"2024","journal-title":"Front Immunol"},{"key":"2025123022310402000_13.12.e012416.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.008"},{"key":"2025123022310402000_13.12.e012416.11","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030558","article-title":"PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer","volume":"13","author":"Rizzo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2025123022310402000_13.12.e012416.12","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.14110.1038\/nrclinonc.2017.141"},{"key":"2025123022310402000_13.12.e012416.13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1148\/radiol.210518","article-title":"Emerging and Evolving Concepts in Cancer Immunotherapy Imaging","volume":"306","author":"Dercle","year":"2023","journal-title":"Radiology"},{"key":"2025123022310402000_13.12.e012416.14","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/S1470-2045(22)00742-2","article-title":"Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshop","volume":"24","author":"Shankar","year":"2023","journal-title":"Lancet Oncol"},{"key":"2025123022310402000_13.12.e012416.15","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004848","article-title":"Imaging approaches and radiomics: toward a new era of ultraprecision radioimmunotherapy?","volume":"10","author":"Sun","year":"2022","journal-title":"J Immunother Cancer"},{"key":"2025123022310402000_13.12.e012416.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.11.2226"},{"key":"2025123022310402000_13.12.e012416.17","doi-asserted-by":"crossref","first-page":"8231","DOI":"10.1245\/s10434-023-14253-1","article-title":"Radiomics Nomogram with Added Nodal Features Improves Treatment Response Prediction in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Study","volume":"30","author":"Li","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"2025123022310402000_13.12.e012416.18","doi-asserted-by":"crossref","first-page":"984","DOI":"10.21147\/j.issn.1000-9604.2019.06.14","article-title":"Prediction of pathological nodal stage of locally advanced rectal cancer by collective features of multiple lymph nodes in magnetic resonance images before and after neoadjuvant chemoradiotherapy","volume":"31","author":"Zhu","year":"2019","journal-title":"Chin J Cancer Res"},{"key":"2025123022310402000_13.12.e012416.19","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/s12885-025-13905-7","article-title":"Prediction of pathological complete response to neoadjuvant chemoimmunotherapy in non\u2013small cell lung cancer using 18F-FDG PET radiomics features of primary tumour and lymph nodes","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Cancer"},{"key":"2025123022310402000_13.12.e012416.20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.7591"},{"key":"2025123022310402000_13.12.e012416.21","doi-asserted-by":"publisher","DOI":"10.1126\/science.7112116"},{"key":"2025123022310402000_13.12.e012416.22","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1007\/s00330-022-08914-0","article-title":"CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study","volume":"32","author":"Jiao","year":"2022","journal-title":"Eur Radiol"},{"key":"2025123022310402000_13.12.e012416.23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1148\/radiol.2018181408","article-title":"Biliary Tract Cancer at CT: A Radiomics-based Model to Predict Lymph Node Metastasis and Survival Outcomes","volume":"290","author":"Ji","year":"2019","journal-title":"Radiology"},{"key":"2025123022310402000_13.12.e012416.24","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1007\/s00330-023-10108-1","article-title":"Radiomics using CT images for preoperative prediction of lymph node metastasis in perihilar cholangiocarcinoma: a multi-centric study","volume":"34","author":"Zhan","year":"2024","journal-title":"Eur Radiol"},{"key":"2025123022310402000_13.12.e012416.25","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1007\/s00330-020-07524-y","article-title":"Intrahepatic cholangiocarcinoma: MRI texture signature as predictive biomarkers of immunophenotyping and survival","volume":"31","author":"Zhang","year":"2021","journal-title":"Eur Radiol"},{"key":"2025123022310402000_13.12.e012416.26","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-000910","article-title":"Machine learning: an approach to preoperatively predict PD-1\/PD-L1 expression and outcome in intrahepatic cholangiocarcinoma using MRI biomarkers","volume":"5","author":"Zhang","year":"2020","journal-title":"ESMO Open"},{"key":"2025123022310402000_13.12.e012416.27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5582\/bst.2024.01121","article-title":"A predictive radiotranscriptomics model based on DCE-MRI for tumor immune landscape and immunotherapy in cholangiocarcinoma","volume":"18","author":"Chen","year":"2024","journal-title":"Biosci Trends"},{"key":"2025123022310402000_13.12.e012416.28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/RLI.0000000000000530","article-title":"Robustness and Reproducibility of Radiomics in Magnetic Resonance Imaging: A Phantom Study","volume":"54","author":"Bae\u00dfler","year":"2019","journal-title":"Invest Radiol"},{"key":"2025123022310402000_13.12.e012416.29","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/jmri.28191","article-title":"Investigation of the Inter- and Intrascanner Reproducibility and Repeatability of Radiomics Features in T1-Weighted Brain MRI","volume":"56","author":"Mitchell-Hay","year":"2022","journal-title":"J Magn Reson Imaging"},{"key":"2025123022310402000_13.12.e012416.30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/RLI.0000000000001026","article-title":"Physics-Informed Discretization for Reproducible and Robust Radiomic Feature Extraction Using Quantitative MRI","volume":"59","author":"Zhao","year":"2024","journal-title":"Invest Radiol"},{"key":"2025123022310402000_13.12.e012416.31","doi-asserted-by":"crossref","first-page":"105318","DOI":"10.1016\/j.compbiomed.2022.105318","article-title":"The potential of prostate gland radiomic features in identifying the Gleason score","volume":"144","author":"Gong","year":"2022","journal-title":"Comput Biol Med"},{"key":"2025123022310402000_13.12.e012416.32","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1109\/JBHI.2020.3002805","article-title":"2D and 3D CT Radiomic Features Performance Comparison in Characterization of Gastric Cancer: A Multi-Center Study","volume":"25","author":"Meng","year":"2021","journal-title":"IEEE J Biomed Health Inform"},{"key":"2025123022310402000_13.12.e012416.33","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04625-9"},{"key":"2025123022310402000_13.12.e012416.34","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1007\/s00330-020-06847-0","article-title":"Radiomics-based prediction model for outcomes of PD-1\/PD-L1 immunotherapy in metastatic urothelial carcinoma","volume":"30","author":"Park","year":"2020","journal-title":"Eur Radiol"},{"key":"2025123022310402000_13.12.e012416.35","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1158\/2159-8290.CD-24-1033","article-title":"Vascular Normalization Augments the Antitumor Efficacy of Combined HDAC Inhibitor with Immunotherapy in Solid Tumors","volume":"15","author":"Wang","year":"2025","journal-title":"Cancer Discov"},{"key":"2025123022310402000_13.12.e012416.36","first-page":"140","article-title":"Enhancing PD-1 blockade in NSCLC: Reprogramming tumor immune microenvironment with albumin-bound statins targeting lipid rafts and mitochondrial respiration","volume":"49","author":"Chen","year":"2025","journal-title":"Bioact Mater"},{"key":"2025123022310402000_13.12.e012416.37","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2020-016808"},{"key":"2025123022310402000_13.12.e012416.38","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/s41416-023-02437-1","article-title":"Checkpoint inhibitors and anti-angiogenic agents: a winning combination","volume":"129","author":"Brest","year":"2023","journal-title":"Br J Cancer"},{"key":"2025123022310402000_13.12.e012416.39","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-00500-y"},{"key":"2025123022310402000_13.12.e012416.40","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/ijc.34372","article-title":"Feasibility and tolerability of sintilimab plus anlotinib as the second-line therapy for patients with advanced biliary tract cancers: An open-label, single-arm, phase II clinical trial","volume":"152","author":"Jin","year":"2023","journal-title":"Int J Cancer"},{"key":"2025123022310402000_13.12.e012416.41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.946861","article-title":"Lenvatinib Plus Programmed Cell Death Protein-1 Inhibitor Beyond First-Line Systemic Therapy in Refractory Advanced Biliary Tract Cancer: A Real-World Retrospective Study in China","volume":"13","author":"Shi","year":"2022","journal-title":"Front Immunol"},{"key":"2025123022310402000_13.12.e012416.42","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7195373","article-title":"Distant Metastases in Patients with Intrahepatic Cholangiocarcinoma: Does Location Matter? A Retrospective Analysis of 370 Patients","volume":"2020","author":"Hahn","year":"2020","journal-title":"J Oncol"},{"key":"2025123022310402000_13.12.e012416.43","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1148\/radiol.220329","article-title":"Artificial Intelligence to Predict Lymph Node Metastasis at CT in Pancreatic Ductal Adenocarcinoma","volume":"306","author":"Bian","year":"2023","journal-title":"Radiology"},{"key":"2025123022310402000_13.12.e012416.44","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61903-0"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2025-012416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T06:31:16Z","timestamp":1767162676000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2025-012416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":44,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,30]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/jitc-2025-012416"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2025-012416","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}